Septal Alcohol Ablation Criteria in Hypertrophic Obstructive Cardiomyopathy
Alcohol septal ablation should be performed only in adult patients with obstructive HCM who meet three specific criteria: severe drug-refractory symptoms (NYHA class III-IV), LVOT gradient ≥50 mmHg, and adequate septal thickness for safe ablation, performed exclusively at experienced HCM centers. 1
Mandatory Eligibility Criteria
All three criteria must be met simultaneously 1:
1. Clinical Criteria
- Severe dyspnea or chest pain (typically NYHA functional class III or IV) 1
- Occasionally other exertional symptoms (syncope or near-syncope) that interfere with everyday activity or quality of life 1
- Symptoms must persist despite optimal medical therapy (maximized beta-blockers, calcium channel blockers, or disopyramide) 1
2. Hemodynamic Criteria
- Dynamic LVOT gradient ≥50 mmHg at rest or with physiologic provocation 1
- Must be associated with septal hypertrophy and systolic anterior motion (SAM) of the mitral valve 1
3. Anatomic Criteria
- Targeted anterior septal thickness sufficient to perform the procedure safely and effectively in the operator's judgment 1
- The procedure is generally discouraged in patients with marked septal hypertrophy >30 mm due to uncertain effectiveness 1
Specific Indications by Clinical Context
Class I Indication (Recommended)
Alcohol septal ablation is recommended when: 1
- Surgery is contraindicated OR
- Surgical risk is unacceptable due to serious comorbidities or advanced age 1
- Patient meets all three eligibility criteria above 1
Class IIb Indication (May Be Considered)
Alcohol septal ablation may be considered as an alternative to surgical myectomy when: 1
- Patient meets all eligibility criteria 1
- After balanced and thorough discussion, patient expresses preference for septal ablation over surgery 1
- Performed at experienced HCM centers 1
Absolute Contraindications (Class III: Harm)
Do NOT perform alcohol septal ablation in: 1
- Patients <21 years of age (contraindicated) 1
- Adults <40 years of age if myectomy is viable (discouraged) 1
- Asymptomatic patients with normal exercise tolerance 1
- Patients with controlled symptoms on optimal medical therapy 1
- Patients with concomitant cardiac disease requiring surgical correction (e.g., multivessel CAD requiring CABG, mitral valve disease requiring repair, valvular aortic stenosis) where surgical myectomy can be performed simultaneously 1
Center and Operator Requirements
Critical caveat: Alcohol septal ablation must only be performed at experienced HCM centers with demonstrated excellence 1:
- Individual operator: Cumulative case volume of ≥20 procedures 1
- OR working in dedicated HCM program: Cumulative total of ≥50 procedures 1
- Center volume >50 patients is an independent predictor of superior outcomes 2
- Must be part of a comprehensive HCM clinical program with longitudinal multidisciplinary care 1
Target Outcomes for Quality Centers
Expected outcomes at experienced centers: 1
- 30-day mortality: ≤1% 1
- Complete heart block requiring permanent pacemaker: ≤10% 1
- Symptomatic improvement (≥1 NYHA class): >90% 1
- Rest and provoked LVOT gradient <50 mmHg: >90% 1
- Repeat procedure rate: ≤10% 1
Predictors of Optimal Outcomes
Patients most likely to benefit from alcohol septal ablation have: 2
- Age ≥65 years 2
- LVOT gradient <100 mmHg 2
- Septal hypertrophy ≤18 mm 2
- Left anterior descending artery diameter <4.0 mm 2
Patients with ≥3 of these characteristics achieve 90.4% 4-year survival free of death and severe symptoms, compared to 57.5% in those with ≤1 characteristic. 2
Important Clinical Pitfalls
- Never perform alcohol septal ablation outside a dedicated HCM program 1
- Surgical myectomy remains the first consideration for most eligible patients, particularly younger patients without surgical contraindications 1
- Consultation with centers offering both surgical myectomy and alcohol ablation is reasonable to ensure patients understand all treatment options 1
- Distal obstruction after repeat ablation is associated with more frequent fatal arrhythmias and need for third interventions compared to proximal obstruction 3